Valuation (28%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.45 | 18.25 |
| PEG Ratio (TTM) | 0.01 | -0.05 |
| P/S Ratio (TTM) | 0.35 | 0.54 |
| P/B Ratio (TTM) | 3.09 | 1.39 |
| P/FCF Ratio (TTM) | -2.14 | 13.41 |
| Price to 5YR AVG Earnings Ratio | -0.83 | 15.59 |
| Price to 5YR AVG FCF Ratio | -1.29 | 63.17 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -41.73% | 4.46% |
| ROE (TTM) | -98.21% | 9.84% |
| Net Profit Margin (TTM) | -77.05% | 1.28% |
| ROIC 5YR AVG | -19.28% | 12.15% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -33.43% | -50.88% | -64.13% |
| Revenue | -7.07% | -12.32% | -10.34% |
| Net Income | -36.99% | -66.00% | -73.35% |
| Cash Flow | -547.74% | -101.00% | -47.20% |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.85 | 2.01 |
| Quick Ratio (TTM) | 0.37 | 1.20 |
| D/E Ratio (TTM) | 0.05 | 0.52 |
| Interest Coverage (TTM) | -3.47 | 4.52 |
| Piotroski F-Score | 3 | 7 |
| Altman Z-Score | N/A | 3.95 |
| LTL to 5YR AVG FCF | -0.34 | 18.54 |
| Shares Outstanding Growth 5YR AVG | 8.65% | 0.97% |